Clinical trial
Pediatric Zylet Safety and Efficacy Study
NCT00420628 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00420628 |
|---|---|
| Title | Pediatric Zylet Safety and Efficacy Study |
| Official title | A Safety and Efficacy Study of Zylet® (Loteprednol Etabonate 0.5% and Tobramycin 0.3% Ophthalmic Suspension) Compared to Vehicle in the Management of Lid Inflammation (Chalazion/Hordeolum) in Pediatric Subjects |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chalazion, Hordeolum |
| Intervention type | Drug |
| Interventions | loteprednol etabonate/tobramycin opthalmic suspension, vehicle |
| Enrollment | 108 |
| Start date | Nov 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Jan 11, 2007 |
| Last update posted | Oct 7, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: